Olusola Olanrewaju Oguntolu, MD | |
2900 Felicia St, Ste 102, Nashville, TN 37209-4042 | |
(615) 321-7255 | |
(615) 321-7259 |
Full Name | Olusola Olanrewaju Oguntolu |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 28 Years |
Location | 2900 Felicia St, Nashville, Tennessee |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346244324 | NPI | - | NPPES |
4043600 | Other | TN | BC/BS |
5347585 | Other | TN | AETNA |
3381539 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | MD36290 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tristar Centennial Medical Center | Nashville, TN | Hospital |
Entity Name | Lung Consultants Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174581144 PECOS PAC ID: 2860396348 Enrollment ID: O20031125000843 |
News Archive
New research has found that the US government and schools have made mixed progress to comprehensively address food and beverage marketing practices that put young people's health at risk.
Catasys, Inc., a provider of proprietary big-data based analytics and predictive modeling driven health management services for health plans, announced today that it has signed a national agreement with Humana Behavioral Health to combine its substance abuse care management with Humana clinical programs to address the needs of members experiencing substance abuse challenges.
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
A recent study, conducted at Dartmouth-Hitchcock Medical Center in Lebanon, NH, suggests that more vigilant prescribing guidelines could reduce the number of opioid pills a patient receives after surgery, whilst still meeting pain management needs.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Olusola Olanrewaju Oguntolu, MD 5543 Edmondson Pike, # 44, Nashville, TN 37211-5808 Ph: (615) 321-7255 | Olusola Olanrewaju Oguntolu, MD 2900 Felicia St, Ste 102, Nashville, TN 37209-4042 Ph: (615) 321-7255 |
News Archive
New research has found that the US government and schools have made mixed progress to comprehensively address food and beverage marketing practices that put young people's health at risk.
Catasys, Inc., a provider of proprietary big-data based analytics and predictive modeling driven health management services for health plans, announced today that it has signed a national agreement with Humana Behavioral Health to combine its substance abuse care management with Humana clinical programs to address the needs of members experiencing substance abuse challenges.
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
A recent study, conducted at Dartmouth-Hitchcock Medical Center in Lebanon, NH, suggests that more vigilant prescribing guidelines could reduce the number of opioid pills a patient receives after surgery, whilst still meeting pain management needs.
› Verified 9 days ago
Megan Desai, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Spurthi N Bhatt, MD MPH Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 | |
Aladraine Sands, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 275 Cumberland Bnd, Nashville, TN 37228 Phone: -- |